JP2005530703A - 生物学的に活性な複合体 - Google Patents

生物学的に活性な複合体 Download PDF

Info

Publication number
JP2005530703A
JP2005530703A JP2003573013A JP2003573013A JP2005530703A JP 2005530703 A JP2005530703 A JP 2005530703A JP 2003573013 A JP2003573013 A JP 2003573013A JP 2003573013 A JP2003573013 A JP 2003573013A JP 2005530703 A JP2005530703 A JP 2005530703A
Authority
JP
Japan
Prior art keywords
lactalbumin
cis
complex
protein
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003573013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530703A5 (https=
Inventor
カタリナ・スヴァンボルイ
マーリン・ヴィルヘルミナ・スヴェンソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2005530703A publication Critical patent/JP2005530703A/ja
Publication of JP2005530703A5 publication Critical patent/JP2005530703A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003573013A 2002-03-07 2003-03-07 生物学的に活性な複合体 Abandoned JP2005530703A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205347.8A GB0205347D0 (en) 2002-03-07 2002-03-07 Biologically active complex
PCT/IB2003/001293 WO2003074547A2 (en) 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Publications (2)

Publication Number Publication Date
JP2005530703A true JP2005530703A (ja) 2005-10-13
JP2005530703A5 JP2005530703A5 (https=) 2006-04-20

Family

ID=9932477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003573013A Abandoned JP2005530703A (ja) 2002-03-07 2003-03-07 生物学的に活性な複合体

Country Status (6)

Country Link
US (1) US20050085416A1 (https=)
EP (1) EP1485413A2 (https=)
JP (1) JP2005530703A (https=)
AU (1) AU2003214522A1 (https=)
GB (1) GB0205347D0 (https=)
WO (1) WO2003074547A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023545152A (ja) * 2020-10-06 2023-10-26 リネイン ファルマ アーベー アンフォールディングタンパク質を含む組成物の調製方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
JP2007524708A (ja) * 2004-02-26 2007-08-30 ハムレット・ファルマ・アーベー 血管新生を阻害するラクトアルブミン
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
US8796218B2 (en) 2009-01-09 2014-08-05 Hamlet Pharma Ab Complex and production process
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
ES2613986T3 (es) 2010-11-24 2017-05-29 Hamlet Pharma Ab Complejo biológicamente activo y su preparación
HUE038910T2 (hu) 2012-08-09 2018-12-28 Hamlet Pharma Ab Profilaktikus és gyógytáp terápia
WO2016133991A1 (en) 2015-02-17 2016-08-25 Xylem Ip Uk Sarl Technique for temperature controlling polarimeter sample cells
IT201700104446A1 (it) * 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1032596T3 (da) * 1997-11-21 2007-09-10 Nya Hamlet Pharma Ab Fremgangsmåde til fremstilling af lactalbumin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023545152A (ja) * 2020-10-06 2023-10-26 リネイン ファルマ アーベー アンフォールディングタンパク質を含む組成物の調製方法

Also Published As

Publication number Publication date
GB0205347D0 (en) 2002-04-24
AU2003214522A8 (en) 2003-09-16
WO2003074547A2 (en) 2003-09-12
US20050085416A1 (en) 2005-04-21
AU2003214522A1 (en) 2003-09-16
WO2003074547A3 (en) 2003-11-27
EP1485413A2 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
JP5550634B2 (ja) 新規抗菌ペプチド
JP5679992B2 (ja) 複合体および生産方法
JP5405307B2 (ja) 改善された性質を有する再構成サーファクタント
JP2005530703A (ja) 生物学的に活性な複合体
US20090110756A1 (en) Methods and Compositions Related to PLUNC Surfactant Polypeptides
US20210130394A1 (en) Preparation of biologically active complexes
JP2014129389A (ja) アルツハイマー病治療方法
KR102122088B1 (ko) 재구성된 폐 계면활성제
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
WO2007043870A1 (en) Leucine rich composition
JP2023539476A (ja) アネキシンａ１のｎ末端ペプチド製剤及び方法
Schmidt et al. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid
JP2023545152A (ja) アンフォールディングタンパク質を含む組成物の調製方法
KR20230019089A (ko) 바이러스 감염을 치료하기 위한 계면활성제 단백질 d의 용도
UA129439C2 (uk) Рідкий склад аналога глюкагону
Kathir et al. S100A13–lipid interactions—role in the non-classical release of the acidic fibroblast growth factor
US20030207795A1 (en) Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Samy et al. Regulation of IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ peptide, apolipoprotein E and nitric oxide in human neuroglioma
Zaman et al. Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis
EP3329930A1 (en) Pharmaceuctical compositions
TW202245823A (zh) 無穩定劑或實質上無穩定劑之含有天凡諾賽普特（ｔａｎｆａｎｅｒｃｅｐｔ）的穩定眼用組成物
TW202607013A (zh) 一種包含ｐｓｄ－９５多肽抑制劑的醫藥組成物及其製備方法
WO2026012337A1 (zh) 一种包含psd-95多肽抑制剂的药物组合物及其制备方法
Harrington Age and cataract-related degradation of crystallins in human lenses
ITMI940621A1 (it) Uso della 4'-desossi-4'-idodoxorubicina per il trattamento della al amiloidosi nella malattia di alzheimer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070625

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080214

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20090318